First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023.

COVID-19 SARS-CoV-2 WGS diagnostic preparedness emerging variant epidemiological preparedness sequencing virus wastewater surveillance

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
09 2023
Historique:
medline: 8 9 2023
pubmed: 7 9 2023
entrez: 7 9 2023
Statut: ppublish

Résumé

We describe 10 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant BA.2.86 detected in Denmark, including molecular characteristics and results from wastewater surveillance that indicate that the variant is circulating in the country at a low level. This new variant with many spike gene mutations was classified as a variant under monitoring by the World Health Organization on 17 August 2023. Further global monitoring of COVID-19, BA.2.86 and other SARS-CoV-2 variants is highly warranted.

Identifiants

pubmed: 37676147
doi: 10.2807/1560-7917.ES.2023.28.36.2300460
pmc: PMC10486197
doi:

Substances chimiques

Wastewater 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
PLoS One. 2022 Oct 5;17(10):e0274889
pubmed: 36197885
BMC Evol Biol. 2007 Nov 08;7:214
pubmed: 17996036
APMIS. 2021 Jul;129(7):438-451
pubmed: 33949007
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Mol Biol Evol. 2021 Jun 25;38(7):3022-3027
pubmed: 33892491
PLoS Biol. 2021 Feb 25;19(2):e3001091
pubmed: 33630831
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Emerg Infect Dis. 2023 Aug;29(8):1589-1597
pubmed: 37486168
Nature. 2022 Sep;609(7925):101-108
pubmed: 35798029
Nat Commun. 2022 Sep 30;13(1):5760
pubmed: 36180438

Auteurs

Morten Rasmussen (M)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.
These authors contributed equally to this work and share first authorship.

Frederik Trier Møller (FT)

These authors contributed equally to this work and share first authorship.
Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Vithiagaran Gunalan (V)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Sharmin Baig (S)

Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.

Marc Bennedbæk (M)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Lasse Engbo Christiansen (LE)

Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.

Arieh Sierra Cohen (AS)

TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.

Kirsten Ellegaard (K)

Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.

Anders Fomsgaard (A)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Kristina Træholt Franck (KT)

Virus Surveillance and Research Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Nicolai Balle Larsen (NB)

TestCenter Denmark, Statens Serum Institut, Copenhagen, Denmark.

Tine Graakjær Larsen (TG)

Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Ria Lassaunière (R)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Charlotta Polacek (C)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Amanda Gammelby Qvesel (AG)

Virus Surveillance and Research Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Raphael Niklaus Sieber (RN)

Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.

Lasse Dam Rasmussen (LD)

Virus Surveillance and Research Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Marc Stegger (M)

Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.
Antimicrobial Resistance and Infectious Diseases Laboratory, Harry Butler Institute, Murdoch University, Perth, Australia.

Katja Spiess (K)

Virus Research and Development Laboratory, Virus & Microbiological Special Diagnostics, Statens Serum Institut, Copenhagen, Denmark.

Man-Hung Eric Tang (ME)

Sequencing and Bioinformatics, Bacteria, Parasites & Fungi, Statens Serum Institut, Copenhagen, Denmark.

Lasse Skafte Vestergaard (LS)

Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.

Thomas Emil Andersen (TE)

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.

Silje Vermedal Hoegh (SV)

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.

Rune Micha Pedersen (RM)

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.

Marianne Nielsine Skov (MN)

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.

Kat Steinke (K)

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.

Thomas Vognbjerg Sydenham (TV)

Department of Clinical Microbiology, Odense University Hospital, Odense, Denmark.
Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark.

Morten Hoppe (M)

Department of Clinical Microbiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.

Lene Nielsen (L)

Department of Clinical Microbiology, Copenhagen University Hospital, Herlev and Gentofte, Denmark.

Tyra Grove Krause (TG)

Epidemiological Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.

Henrik Ullum (H)

Statens Serum Institut, Copenhagen, Denmark.

Pikka Jokelainen (P)

Infectious Disease Preparedness, Statens Serum Institut, Copenhagen, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH